http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101767802-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2506-45 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2503-02 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-067 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-071 |
filingDate | 2014-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2017-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2017-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-101767802-B1 |
titleOfInvention | Compounds for improved stem cell differentiation into hepatocytes |
abstract | The present invention relates to compounds of the general formula (I), or pharmaceutically acceptable salts or esters thereof, wherein: (I) Wherein R 1 to R 11 are as defined in the specification and claims. The present invention also relates to compounds of formula I and to their use and to the use of the pharmaceutical compositions containing such compounds. The compounds of formula I are useful as drug screening platforms and to differentiate stem cells into more mature or adult-like hepatocytes for use in disease modeling applications. |
priorityDate | 2013-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 118.